研究人员假设，与单独使用 CADe 系统相比，结合使用 CADe 系统（ENDOAID）与黏膜暴露装置（Endocuff Vision®）可改善腺瘤检测率。
适应症：Adenoma、Colorectal Cancer、Colorectal Neoplasms
入组条件
纳入标准
- Aged 45-85 years old;
- They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or altered bowel habit;
- Written informed consent obtained.
排除标准
- Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)
- Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets)
- Staged procedure for polypectomy or biopsy of known unresected lesions
- Previous surgical resection of colon
- Personal history of colorectal cancer
- Personal history of familial polyposis syndrome
- Personal history of inflammatory bowel disease
- Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
- Pregnancy
- Unable to obtain informed consent
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。